scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Mary Jo Wick | |
Charles Caër | |||
P2860 | cites work | Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes | Q22254042 |
TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine | Q24301263 | ||
Blood monocytes: development, heterogeneity, and relationship with dendritic cells | Q24314793 | ||
Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development | Q24645273 | ||
Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease | Q24653651 | ||
Monocyte Heterogeneity: Consequences for Monocyte-Derived Immune Cells | Q26740174 | ||
The development and maintenance of resident macrophages | Q26774975 | ||
Breast Milk and Solid Food Shaping Intestinal Immunity | Q26782801 | ||
Cross-Presentation of Cell-Associated Antigens by MHC Class I in Dendritic Cell Subsets | Q26799991 | ||
Immunomodulatory functions of type I interferons | Q26823904 | ||
Resolution of inflammation: an integrated view | Q26852569 | ||
Tissue-resident macrophages | Q26991488 | ||
Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and Functions | Q26995456 | ||
Beyond oxidative stress: an immunologist's guide to reactive oxygen species | Q27011356 | ||
Oral tolerance to food protein | Q27026259 | ||
Control of adaptive immunity by the innate immune system | Q27026513 | ||
Development and Function of Secondary and Tertiary Lymphoid Organs in the Small Intestine and the Colon | Q28071695 | ||
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood | Q28138201 | ||
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL | Q28216755 | ||
Dysbiosis and the immune system | Q36297601 | ||
Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease. | Q36298256 | ||
Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells | Q36333494 | ||
The mononuclear phagocyte system | Q36336169 | ||
Homeostatic Immunity and the Microbiota | Q36351062 | ||
Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation | Q36381535 | ||
ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation | Q36520874 | ||
Neuro-immune Interactions Drive Tissue Programming in Intestinal Macrophages | Q36522011 | ||
Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets | Q36569494 | ||
The TREM receptor family and signal integration | Q36655903 | ||
Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis | Q36667276 | ||
The multifaceted biology of plasmacytoid dendritic cells | Q36731249 | ||
Intrinsic Gastrointestinal Macrophages: Their Phenotype and Role in Gastrointestinal Motility | Q36754839 | ||
Absence of MHC class II on cDCs results in microbial-dependent intestinal inflammation | Q36767470 | ||
Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors | Q36775202 | ||
Classical dendritic cells are required for dietary antigen-mediated induction of peripheral T(reg) cells and tolerance | Q36814061 | ||
Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ-resident dendritic cells | Q36822691 | ||
IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses | Q36882237 | ||
NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. | Q37002001 | ||
Retinoic acid-dependent regulation of immune responses by dendritic cells and macrophages | Q37096952 | ||
Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. | Q37194936 | ||
CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis. | Q37238312 | ||
Intestinal macrophages and response to microbial encroachment | Q37292224 | ||
Unsupervised High-Dimensional Analysis Aligns Dendritic Cells across Tissues and Species | Q37293474 | ||
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease | Q37331540 | ||
Specification of tissue-resident macrophages during organogenesis. | Q37343167 | ||
Transcriptional Control of Dendritic Cell Development. | Q37468541 | ||
Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. | Q37483138 | ||
Hypoxia and Mucosal Inflammation. | Q37550577 | ||
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition | Q37587618 | ||
Role of Regulatory Cells in Oral Tolerance | Q37606265 | ||
Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice. | Q37616722 | ||
Intestinal bacteria and the regulation of immune cell homeostasis | Q37700728 | ||
Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation | Q37700828 | ||
Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate | Q28298291 | ||
Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells | Q28591976 | ||
Immunobiology of dendritic cells | Q29547465 | ||
Fate mapping analysis reveals that adult microglia derive from primitive macrophages | Q29616177 | ||
Genetics and pathogenesis of inflammatory bowel disease | Q29616350 | ||
Development of monocytes, macrophages, and dendritic cells | Q29616446 | ||
The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting | Q29618424 | ||
A lineage of myeloid cells independent of Myb and hematopoietic stem cells | Q29620147 | ||
Intestinal homeostasis and its breakdown in inflammatory bowel disease | Q29620336 | ||
Macrophage biology in development, homeostasis and disease | Q29620350 | ||
Protective and pathogenic functions of macrophage subsets | Q29620351 | ||
Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease | Q30054715 | ||
Crohn's disease | Q30240201 | ||
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease | Q30243958 | ||
Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease | Q30658251 | ||
Targeted Delivery of Immunomodulators to Lymph Nodes | Q30794718 | ||
Tissue macrophages: heterogeneity and functions | Q32173810 | ||
Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. | Q33361113 | ||
Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection | Q33569384 | ||
Phenotype, function, and differentiation potential of human monocyte subsets. | Q33606028 | ||
The microbiome in inflammatory bowel disease: current status and the future ahead | Q33664898 | ||
Inflammatory cues enhance TGFβ activation by distinct subsets of human intestinal dendritic cells via integrin αvβ8. | Q33712534 | ||
Role of the microbiota in immunity and inflammation | Q33752553 | ||
The treatment-naive microbiome in new-onset Crohn's disease | Q33762817 | ||
The fate and lifespan of human monocyte subsets in steady state and systemic inflammation | Q33886544 | ||
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. | Q33902330 | ||
The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells | Q33902379 | ||
Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells | Q33902421 | ||
Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation | Q33911451 | ||
Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis | Q33914907 | ||
Anatomical basis of tolerance and immunity to intestinal antigens | Q33965210 | ||
Role of the gut microbiota in immunity and inflammatory disease | Q34036490 | ||
The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells | Q34052310 | ||
Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities | Q34087190 | ||
Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility. | Q34109011 | ||
Nomenclature of monocytes and dendritic cells in blood. | Q34125860 | ||
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. | Q41846031 | ||
Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1. | Q41986614 | ||
Origin of the lamina propria dendritic cell network | Q42117974 | ||
Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. | Q42138485 | ||
CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNF | Q42142744 | ||
Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease. | Q42229506 | ||
Functional heterogeneity of gut-resident regulatory T cells | Q42279415 | ||
The Peyer's Patch Mononuclear Phagocyte System at Steady State and during Infection | Q42371903 | ||
IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo | Q42772715 | ||
Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3(+) regulatory T cells | Q42830424 | ||
Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. | Q43081763 | ||
Phagocytosis imprints heterogeneity in tissue-resident macrophages. | Q43097066 | ||
An Antibody Against Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1) Dampens Proinflammatory Cytokine Secretion by Lamina Propria Cells from Patients with IBD. | Q43754792 | ||
Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses | Q44318177 | ||
Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease | Q44369423 | ||
Origin of monocytes and macrophages in a committed progenitor | Q45159606 | ||
Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo | Q45193405 | ||
Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability. | Q45932216 | ||
Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. | Q45943518 | ||
Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro. | Q45987643 | ||
Environmental triggers in IBD: a review of progress and evidence. | Q46026239 | ||
Chemokines in Inflammatory Bowel Diseases | Q46790868 | ||
Lineage specification of human dendritic cells is marked by IRF8 expression in hematopoietic stem cells and multipotent progenitors. | Q47113381 | ||
Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. | Q47132433 | ||
Transcriptional and functional profiling defines human small intestinal macrophage subsets. | Q47256407 | ||
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases | Q47260453 | ||
High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. | Q47314216 | ||
Existence of CD8α-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species | Q47607521 | ||
Identification of cDC1- and cDC2-committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow. | Q47687570 | ||
Human CD1c⁺ myeloid dendritic cells acquire a high level of retinoic acid-producing capacity in response to vitamin D₃. | Q47727563 | ||
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. | Q47758448 | ||
Aryl Hydrocarbon Receptor Controls Monocyte Differentiation into Dendritic Cells versus Macrophages | Q47772617 | ||
Identification of a Human Clonogenic Progenitor with Strict Monocyte Differentiation Potential: A Counterpart of Mouse cMoPs | Q47841621 | ||
T Cell Zone Resident Macrophages Silently Dispose of Apoptotic Cells in the Lymph Node | Q47962765 | ||
CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi. | Q48257612 | ||
Yolk sac macrophage progenitors traffic to the embryo during defined stages of development. | Q48293548 | ||
Macrophage Clearance of Apoptotic Cells: A Critical Assessment | Q49197192 | ||
Lymph node macrophages: Scavengers, immune sentinels and trophic effectors | Q49346577 | ||
Niche signals and transcription factors involved in tissue-resident macrophage development | Q49793888 | ||
Dendritic Cells on the Way to Glory | Q49873903 | ||
Human in vivo-differentiated monocyte-derived dendritic cells | Q49968553 | ||
Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier | Q49990746 | ||
Human T Cell Development, Localization, and Function throughout Life | Q50024233 | ||
Human Intestinal Dendritic Cells in Inflammatory Bowel Diseases. | Q50036423 | ||
IgA Function in Relation to the Intestinal Microbiota. | Q50063230 | ||
Chemoreceptors in the Gut. | Q50065555 | ||
Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. | Q50098206 | ||
Macrophage plasticity, polarization and function in health and disease | Q50107325 | ||
Human dendritic cell subsets: an update | Q50125373 | ||
CD16+ Macrophages Mediate Fibrosis in Inflammatory Bowel Disease. | Q50162390 | ||
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific | Q58861966 | ||
Dynamics of Colon Monocyte and Macrophage Activation During Colitis | Q59806949 | ||
Origin, Differentiation, and Function of Intestinal Macrophages | Q59806954 | ||
Intestinal Dendritic Cells in Health and Gut Inflammation | Q60046084 | ||
Characteristics of Intestinal Dendritic Cells in Inflammatory Bowel Diseases | Q60175418 | ||
Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease | Q61135846 | ||
‘NOTCHing up’ the In Vitro Production of Dendritic Cells | Q63409622 | ||
Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis | Q64056525 | ||
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases | Q64107231 | ||
IgG and Fcγ Receptors in Intestinal Immunity and Inflammation | Q64118813 | ||
Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease | Q64261195 | ||
The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages | Q64261973 | ||
Coordination of Immune-Stroma Crosstalk by IL-6 Family Cytokines. | Q64999676 | ||
Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa | Q70801967 | ||
Migration and maturation of human colonic dendritic cells | Q73720830 | ||
In vivo generation of human dendritic cell subsets by Flt3 ligand | Q74055026 | ||
Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation | Q74262578 | ||
Mucosal IL-8 and TGF-beta recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells | Q79774355 | ||
Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine | Q81178366 | ||
Relationship between human intestinal dendritic cells, gut microbiota, and disease activity in Crohn's disease | Q84936754 | ||
Differential accumulation and function of proinflammatory 6-sulfo LacNAc dendritic cells in lymph node and colon of Crohn's versus ulcerative colitis patients | Q85570375 | ||
Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells | Q85634389 | ||
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease | Q86952010 | ||
Of Human DC Migrants and Residents | Q87636428 | ||
The Intestinal Epithelium: Central Coordinator of Mucosal Immunity | Q88536694 | ||
Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease | Q88580366 | ||
Ulcerative colitis | Q88899916 | ||
TNF-anti-TNF Immune Complexes Inhibit IL-12/IL-23 Secretion by Inflammatory Macrophages via an Fc-dependent Mechanism | Q88961384 | ||
The human heart contains distinct macrophage subsets with divergent origins and functions | Q89070227 | ||
Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier | Q89108679 | ||
Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells | Q89171096 | ||
Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL-22Fc): A Potential Therapy for Epithelial Injury | Q89305209 | ||
Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses | Q89448413 | ||
Intestinal macrophages and their interaction with the enteric nervous system in health and inflammatory bowel disease | Q89585472 | ||
Transcriptomic Analysis and High-dimensional Phenotypic Mapping of Mononuclear Phagocytes in Mesenteric Lymph Nodes Reveal Differences Between Ulcerative Colitis and Crohn's Disease | Q90197813 | ||
TREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients? | Q90214239 | ||
Progress on Modulating Tumor-Associated Macrophages with Biomaterials | Q90323293 | ||
Gut microbiome structure and metabolic activity in inflammatory bowel disease | Q90371831 | ||
Transcriptional profiling reveals monocyte-related macrophages phenotypically resembling DC in human intestine | Q90427375 | ||
Two distinct colonic CD14+ subsets characterized by single-cell RNA profiling in Crohn's disease | Q91168567 | ||
Immunometabolism at the interface between macrophages and pathogens | Q91212060 | ||
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways | Q91296899 | ||
Itaconate: the poster child of metabolic reprogramming in macrophage function | Q91297760 | ||
Review article: managing the adverse events caused by anti-TNF therapy in inflammatory bowel disease | Q91419203 | ||
A blood-based prognostic biomarker in IBD | Q91570983 | ||
Mediators of the Resolution of the Inflammatory Response | Q91647560 | ||
Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases | Q91868246 | ||
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD | Q91937728 | ||
Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor | Q91970764 | ||
Inflammation triggers immediate rather than progressive changes in monocyte differentiation in the small intestine | Q92034675 | ||
Development and functional specialization of CD103+ dendritic cells. | Q37700854 | ||
Mucosal macrophages in intestinal homeostasis and inflammation | Q37949275 | ||
How vitamin A metabolizing dendritic cells are generated in the gut mucosa | Q37955483 | ||
The three human monocyte subsets: implications for health and disease | Q37995036 | ||
Sargramostim (GM-CSF) for induction of remission in Crohn's disease: a cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials | Q38007115 | ||
Paneth cells: maestros of the small intestinal crypts | Q38080558 | ||
The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target | Q38161542 | ||
Intestinal epithelial cells: regulators of barrier function and immune homeostasis | Q38190874 | ||
Intestinal macrophages and dendritic cells: what's the difference? | Q38209216 | ||
Intestinal dendritic cells in the regulation of mucosal immunity | Q38221347 | ||
Origin and functions of tissue macrophages. | Q38230878 | ||
Dendritic cells and monocyte-derived cells: Two complementary and integrated functional systems | Q38468896 | ||
SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset | Q38487146 | ||
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. | Q38539817 | ||
A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets. | Q38576179 | ||
Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment | Q38636864 | ||
Role of Intestinal HIF-2α in Health and Disease | Q38669208 | ||
CCR2-dependent monocyte-derived macrophages resolve inflammation and restore gut motility in postoperative ileus | Q38671025 | ||
Genetics and Pathogenesis of Inflammatory Bowel Disease | Q38747192 | ||
Current and emerging therapeutic targets for IBD. | Q38763559 | ||
Resolution of inflammation: a new therapeutic frontier | Q38791244 | ||
Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases | Q38805575 | ||
Role of Monocytes and Intestinal Macrophages in Crohn's Disease and Ulcerative Colitis | Q38848938 | ||
Human haematopoietic stem cell lineage commitment is a continuous process | Q38893856 | ||
Macrophages in gastrointestinal homeostasis and inflammation. | Q38913938 | ||
Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases | Q38976561 | ||
Functions of Murine Dendritic Cells | Q38985483 | ||
The intestinal epithelial barrier: a therapeutic target? | Q39009998 | ||
Dendritic cell migration in health and disease | Q39021691 | ||
Novel Targeted Therapies for Inflammatory Bowel Disease | Q39028822 | ||
Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease. | Q39031925 | ||
Mechanisms of Organ Injury and Repair by Macrophages | Q39037455 | ||
Retinoic Acid and Immune Homeostasis: A Balancing Act. | Q39091685 | ||
Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. | Q39105607 | ||
Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication | Q39113709 | ||
CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis | Q50533232 | ||
CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. | Q50787445 | ||
Human inflammatory dendritic cells induce Th17 cell differentiation. | Q50917340 | ||
IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. | Q51002504 | ||
Macrophages and the Recovery from Acute and Chronic Inflammation. | Q51270292 | ||
Apoptosis and Clearance of Apoptotic Cells. | Q51366322 | ||
Regulation of the Cell Biology of Antigen Cross-Presentation. | Q51410365 | ||
The Complexity of alpha E beta 7 Blockade in Inflammatory Bowel Diseases. | Q51471341 | ||
Long-term persistence of human donor alveolar macrophages in lung transplant recipients. | Q51503858 | ||
Reprogramming of monocytes by GM-CSF contributes to regulatory immune functions during intestinal inflammation. | Q51661405 | ||
Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. | Q51869621 | ||
TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. | Q51889710 | ||
Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease. | Q52314229 | ||
Urbanization and the gut microbiota in health and inflammatory bowel disease. | Q52579441 | ||
Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. | Q52602187 | ||
Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease. | Q52618987 | ||
Rapid accumulation of CD14+CD11c+ dendritic cells in gut mucosa of celiac disease after in vivo gluten challenge | Q34206293 | ||
Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice | Q34214131 | ||
Human dermal CD14⁺ cells are a transient population of monocyte-derived macrophages | Q34244161 | ||
The gastrointestinal mucus system in health and disease | Q34332180 | ||
Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity | Q34381271 | ||
Regional specialization within the intestinal immune system | Q34439411 | ||
Macrophages in Tissue Repair, Regeneration, and Fibrosis | Q34518415 | ||
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors | Q34555562 | ||
Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis | Q34646876 | ||
Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes | Q34650719 | ||
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
Macrophages: development and tissue specialization | Q34669239 | ||
Regulation of macrophage development and function in peripheral tissues | Q34674559 | ||
Tissue-Resident Macrophage Ontogeny and Homeostasis | Q34676333 | ||
Intestinal lamina propria dendritic cell subsets have different origin and functions. | Q35001346 | ||
Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation | Q35012024 | ||
Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin | Q35030843 | ||
Circulating precursors of human CD1c+ and CD141+ dendritic cells | Q35161496 | ||
Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow | Q35161508 | ||
Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD. | Q35611467 | ||
Regulatory immune cells in regulation of intestinal inflammatory response to microbiota. | Q35665218 | ||
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms | Q35674290 | ||
Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. | Q35679555 | ||
Immunopathogenesis of IBD: current state of the art. | Q35857951 | ||
Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor. | Q35866588 | ||
Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function | Q35884586 | ||
Reparative inflammation takes charge of tissue regeneration | Q35899475 | ||
Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum | Q35931663 | ||
Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation | Q35946105 | ||
Molecular and cellular mechanisms of food allergy and food tolerance. | Q35984123 | ||
TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases | Q35987572 | ||
Development and maintenance of intestinal regulatory T cells | Q35992122 | ||
Gut microbiota, metabolites and host immunity | Q36031926 | ||
Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues. | Q39136220 | ||
Resident macrophages in the healthy and inflamed intestinal muscularis externa. | Q39150054 | ||
TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives | Q39155066 | ||
Diversity and functions of intestinal mononuclear phagocytes | Q39221260 | ||
Transcriptional control of monocyte and macrophage development | Q39221646 | ||
Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease | Q39256177 | ||
Monocyte differentiation and antigen-presenting functions | Q39258320 | ||
Does niche competition determine the origin of tissue-resident macrophages? | Q39276574 | ||
TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota | Q39324100 | ||
Roles of intestinal epithelial cells in the maintenance of gut homeostasis | Q39331432 | ||
Rapid and Efficient Generation of Regulatory T Cells to Commensal Antigens in the Periphery | Q39343055 | ||
Transcriptional determination and functional specificity of myeloid cells: making sense of diversity | Q39350743 | ||
Inflammation and metabolism in tissue repair and regeneration. | Q39360685 | ||
DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues | Q39374974 | ||
IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively | Q39381290 | ||
Mucosal immune system of the gastrointestinal tract: maintaining balance between the good and the bad. | Q39428969 | ||
Gut microbiota and IBD: causation or correlation? | Q39458190 | ||
Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease | Q39940199 | ||
Differentiation of human monocytes and derived subsets of macrophages and dendritic cells by the HLDA10 monoclonal antibody panel. | Q39979829 | ||
Mapping the human DC lineage through the integration of high-dimensional techniques. | Q40225787 | ||
Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors | Q40252079 | ||
Identification of a human intestinal myeloid cell subset that regulates gut homeostasis. | Q40480972 | ||
Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1+ Dendritic Cells | Q40499828 | ||
Characterization of human blood dendritic cell subsets | Q40625943 | ||
A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF. | Q40667799 | ||
IRF8 Transcription-Factor-Dependent Classical Dendritic Cells Are Essential for Intestinal T Cell Homeostasis. | Q40719461 | ||
New insights into the multidimensional concept of macrophage ontogeny, activation and function. | Q40866271 | ||
Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells | Q40952120 | ||
Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease | Q41459552 | ||
The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor | Q41497311 | ||
Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ. | Q41661113 | ||
CD1c-Expression by Monocytes - Implications for the Use of Commercial CD1c+ Dendritic Cell Isolation Kits | Q36054531 | ||
Immunological aspects of intestinal mucus and mucins. | Q36096975 | ||
Monocyte and macrophage plasticity in tissue repair and regeneration | Q36167571 | ||
Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease | Q36172835 | ||
Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny | Q36263627 | ||
Tracing the origin of adult intestinal stem cells | Q92052877 | ||
Resident memory CD8 T cells persist for years in human small intestine | Q92133770 | ||
The role of macrophages in the resolution of inflammation | Q92153164 | ||
Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis | Q92204349 | ||
Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances | Q92281952 | ||
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases | Q92383004 | ||
IL-12 and Mucosal CD14+ Monocyte-Like Cells Induce IL-8 in Colonic Memory CD4+ T Cells of Patients With Ulcerative Colitis but not Crohn's Disease | Q92804209 | ||
Assessment of Crohn's disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review | Q92827433 | ||
Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2 | Q92830433 | ||
The Mononuclear Phagocytic System. Generation of Diversity | Q92857858 | ||
Plasmacytoid dendritic cells develop from Ly6D+ lymphoid progenitors distinct from the myeloid lineage | Q92860934 | ||
Targeting immune cell circuits and trafficking in inflammatory bowel disease | Q93001372 | ||
Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy | Q93043721 | ||
Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells | Q93044640 | ||
Compartmentalization of dendritic cell and T-cell interactions in the lymph node: Anatomy of T-cell fate decisions | Q93049134 | ||
Microbial genes and pathways in inflammatory bowel disease | Q93088941 | ||
Bridging intestinal immunity and gut microbiota by metabolites | Q93092528 | ||
Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells | Q93151331 | ||
Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease | Q93158351 | ||
Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation | Q93212826 | ||
Dendritic cell subsets in T cell programming: location dictates function | Q93338385 | ||
Risk factors for postoperative infection after gastrointestinal surgery among adult patients with inflammatory bowel disease: Findings from a large observational US cohort study | Q93355863 | ||
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting | Q93381993 | ||
Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. | Q52664145 | ||
Mechanisms of Oral Tolerance. | Q52682112 | ||
Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation. | Q52715871 | ||
Dendritic Cells Display Subset and Tissue-Specific Maturation Dynamics over Human Life. | Q52780418 | ||
Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease. | Q53093762 | ||
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis? | Q53131122 | ||
Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease. | Q53203956 | ||
CD163L1 and CLEC5A discriminate subsets of human resident and inflammatory macrophages in vivo. | Q53543419 | ||
Human intestinal pro-inflammatory CD11chighCCR2+CX3CR1+ macrophages, but not their tolerogenic CD11c-CCR2-CX3CR1- counterparts, are expanded in inflammatory bowel disease. | Q53819683 | ||
Tissue-resident macrophages in the intestine are long lived and defined by Tim-4 and CD4 expression. | Q54201969 | ||
To respond or not to respond - a personal perspective of intestinal tolerance. | Q54264589 | ||
Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. | Q54471973 | ||
CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease. | Q54629123 | ||
Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway. | Q55453765 | ||
Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease | Q57025321 | ||
Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis | Q57025360 | ||
Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease | Q57098797 | ||
The elusive case of human intraepithelial T cells in gut homeostasis and inflammation | Q57143881 | ||
Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models | Q57149911 | ||
miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD | Q57197627 | ||
Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis | Q57339877 | ||
Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria | Q57339886 | ||
Developmental and Functional Heterogeneity of Monocytes | Q57457579 | ||
Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation | Q57792331 | ||
Intestinal fibrosis | Q58568367 | ||
Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance | Q58592065 | ||
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study | Q58604512 | ||
Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells | Q58620994 | ||
ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS-STING | Q58700139 | ||
The Transcription Factor ZEB2 Is Required to Maintain the Tissue-Specific Identities of Macrophages | Q58730196 | ||
Mechanisms regulating intestinal barrier integrity and its pathological implications | Q58774497 | ||
Resolution of chronic inflammatory disease: universal and tissue-specific concepts | Q58778332 | ||
Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity | Q58780459 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | inflammatory bowel diseases | Q917447 |
P304 | page(s) | 410 | |
P577 | publication date | 2020-03-18 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease | |
P478 | volume | 11 |
Search more.